AAAAAA
Results:
1-13
|
Results: 13
Authors:
MAYER A
CHESTER KA
BHATIA J
PEDLEY RB
READ DA
BOXER GM
BEGENT RHJ
Citation: A. Mayer et al., EXEMPLIFYING GUIDELINES FOR PREPARATION OF RECOMBINANT-DNA PRODUCTS IN PHASE-I TRIALS IN CANCER - PREPARATION OF A GENETICALLY-ENGINEERED ANTI-CEA SINGLE-CHAIN FV ANTIBODY, European journal of cancer, 34(7), 1998, pp. 968-976
Authors:
MAYER A
BOXER GM
OMALLEY D
TSIOMPANOU E
FLYNN AA
DAVIDSON BR
WINSLET MC
LEWIS AAM
DHILLON AP
HILSON AJW
BEGENT RHJ
Citation: A. Mayer et al., AN ANTI-CEA SINGLE-CHAIN FV ANTIBODY FOR RADIOIMMUNOGUIDED SURGERY INCOLORECTAL-CANCER, Annals of oncology, 9, 1998, pp. 167-167
Authors:
BOXER GM
MAYER A
OMALLEY D
TSIOMPANOU E
WINSLET MC
LEWIS AAM
DHILLON AP
HILSON AJW
BEGENT RHJ
Citation: Gm. Boxer et al., RADIOIMMUNOGUIDED SURGERY (RIGS) OF COLORECTAL-CANCER WITH SINGLE-CHAIN FV ANTIBODY TO CEA, British Journal of Cancer, 78, 1998, pp. 27-27
Authors:
FLYNN AA
GREEN AJ
BOXER GM
PEDLEY RB
BEGENT RHJ
Citation: Aa. Flynn et al., A DOSIMETRY MODEL FOR THE ACCURATE CHARACTERIZATION OF ABSORBED DOSESIN MOUSE ORGANS, British Journal of Cancer, 78, 1998, pp. 60-60
Authors:
COOKE SP
LAWRENCE L
BOXER GM
CHESTER KA
BEGENT RHJ
Citation: Sp. Cooke et al., PHAGE-DERIVED SINGLE-CHAIN FV ANTIBODY FRAGMENTS TO VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR, British Journal of Cancer, 78, 1998, pp. 91-91
Authors:
PEDLEY RB
SHARMA SK
BODEN R
BOXER GM
SPRINGER CJ
BEGENT RHJ
Citation: Rb. Pedley et al., ENHANCEMENT OF ADEPT WITH ANTI-VASCULATURE DRUGS IN A XENOGRAFT MODEL, British Journal of Cancer, 78, 1998, pp. 106-106
Authors:
WATSON R
BOXER GM
JONES A
Citation: R. Watson et al., QUANTITATION OF CEA AND ESTROGEN-RECEPTOR EXPRESSION IN HUMAN BREAST CANCERS BY RADIOIMMUNOLUMINOGRAPHY, British Journal of Cancer, 78, 1998, pp. 138-138
Authors:
BHATIA J
PEDLEY RB
SHARMA SK
BOXER GM
READ DA
BODEN RW
MICHAEL P
CHESTER KA
BEGENT RHJ
Citation: J. Bhatia et al., A DISTRIBUTION STUDY AT SUBMILLIMETER RESOLUTION OF A RECOMBINANT MFE-23-CPG(2) FUSION PROTEIN IN A COLORECTAL-CANCER XENOGRAFT MODEL, British Journal of Cancer, 78, 1998, pp. 147-147
Authors:
PEDLEY RB
BODEN JA
BODEN R
BOXER GM
FLYNN AA
KEEP PA
BEGENT RHJ
Citation: Rb. Pedley et al., ABLATION OF COLORECTAL XENOGRAFTS WITH COMBINED RADIOIMMUNOTHERAPY AND TUMOR BLOOD FLOW-MODIFYING AGENTS, Cancer research, 56(14), 1996, pp. 3293-3300
Authors:
PEDLEY RB
BEGENT RHJ
BODEN JA
BOXER GM
BODEN R
KEEP PA
Citation: Rb. Pedley et al., ENHANCEMENT OF RADIOIMMUNOTHERAPY BY DRUGS MODIFYING TUMOR BLOOD-FLOWIN A COLONIC XENOGRAFT MODEL, International journal of cancer, 57(6), 1994, pp. 830-835
Authors:
CHESTER KA
ROBSON L
KEEP PA
PEDLEY RB
BODEN JA
BOXER GM
HAWKINS RE
BEGENT RHJ
Citation: Ka. Chester et al., PRODUCTION AND TUMOR-BINDING CHARACTERIZATION OF A CHIMERIC ANTI-CEA FAB EXPRESSED IN ESCHERICHIA-COLI, International journal of cancer, 57(1), 1994, pp. 67-72
Authors:
OLABIRAN Y
LEDERMANN JA
MARSTON NJ
BOXER GM
HICKS R
SOUHAMI RL
SPIRO SG
STAHEL RA
Citation: Y. Olabiran et al., THE SELECTION OF ANTIBODIES FOR TARGETED THERAPY OF SMALL-CELL LUNG-CANCER (SCLC) USING A HUMAN TUMOR SPHEROID MODEL TO COMPARE THE UPTAKE OF CLUSTER-1 AND CLUSTER-W4 ANTIBODIES, British Journal of Cancer, 69(2), 1994, pp. 247-252
Authors:
BOXER GM
ABASSI AM
PEDLEY RB
BEGENT RHJ
Citation: Gm. Boxer et al., LOCALIZATION OF MONOCLONAL-ANTIBODIES REACTING WITH DIFFERENT EPITOPES ON CARCINOEMBRYONIC ANTIGEN (CEA) - IMPLICATIONS FOR TARGETED THERAPY, British Journal of Cancer, 69(2), 1994, pp. 307-314
Risultati:
1-13
|